Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tianjin Zhongxin Pharma Group | Singapore | Healthcare | Pharmaceuticals | SGD 5.04B | 7.1x | 0.1 | SGD 3.69 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Haw Par Corporation Ltd | Singapore | Healthcare | Pharmaceuticals | SGD 3.13B | 13.7x | 2.54 | SGD 14.13 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Hyphens Pharma | Singapore | Healthcare | Pharmaceuticals | SGD 103.47M | 10.1x | 0.6 | SGD 0.34 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 4.5% Upside | Upgrade to Pro+ | |
IX Biopharma Ltd | Singapore | Healthcare | Pharmaceuticals | SGD 16.87M | -1.6x | -0.3 | SGD 0.02 | -5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Pharmesis International Ltd | Singapore | Healthcare | Pharmaceuticals | SGD 14.74M | 9.4x | 0.04 | SGD 0.47 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Suntar Eco-City Ltd | Singapore | Healthcare | Pharmaceuticals | SGD 8.97M | 6.1x | 0.01 | SGD 0.14 | 57.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |